menu
    • menu

    Company profile for Xspray Pharma

    NEW Drugs in Dev: 4
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Xspray was founded in 2003 as a drug delivery company based on the company’s patented nozzle for particle engineering and scale-up. In 2011, Xspray realigned its business model from conducting contract research and development for other pharmaceutical companies to focusing on developing proprietary drugs based on its RightSize™ technology. Xspray is now a pharmaceutical company focused on developing improved and generic ve...
    Xspray was founded in 2003 as a drug delivery company based on the company’s patented nozzle for particle engineering and scale-up. In 2011, Xspray realigned its business model from conducting contract research and development for other pharmaceutical companies to focusing on developing proprietary drugs based on its RightSize™ technology. Xspray is now a pharmaceutical company focused on developing improved and generic versions of already marketed drugs, mainly protein kinase inhibitors (PKIs) for targeted cancer treatment, and aims to be world leader in this field.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Xspray PharmaSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Råsundavägen 12 169 67 Solna
    Telephone
    Telephone
    +46 (0)8 730 37 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://xspraypharma.com/en/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Xspray Hits FDA Wall With New Manufacturing-Related Rejection
    Xspray Hits FDA Wall With New Manufacturing-Related Rejection

    09 Oct 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/fda-throws-cold-water-xsprays-commercialization-hopes-another-rejection-manufacturing-label

    FIERCE PHARMA
    09 Oct 2025
    Share Share
    Xspray Pharma Submits XS003 NDA to FDA From HyNap Platform
    Xspray Pharma Submits XS003 NDA to FDA From HyNap Platform

    19 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250819098597/en/Xspray-Pharma-Submits-XS003-to-the-FDA-The-Companys-Second-Product-Candidate-from-the-HyNap-Platform

    BUSINESSWIRE
    19 Aug 2025
    Share Share
    Xspray Inks Licensing Deal with Handa Therapeutics for Royalties
    Xspray Inks Licensing Deal with Handa Therapeutics for Royalties

    12 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250812575897/en/Xspray-Pharma-Signs-License-Agreement-with-Handa-Therapeutics-to-Receive-up-to-Double-Digit-Royalty-on-Handas-Net-Proceeds

    BUSINESSWIRE
    12 Aug 2025
    Share Share
    Xspray Announces Positive FDA Meeting For Dasynoc NDA Resubmission
    Xspray Announces Positive FDA Meeting For Dasynoc NDA Resubmission

    19 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240919363821/en

    BUSINESSWIRE
    19 Sep 2024
    Share Share
    Scientific Article in Leading Journal Endorses Xspray Pharma's HyNap Technology
    Scientific Article in Leading Journal Endorses Xspray Pharma's HyNap Technology

    06 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240906133856/en

    BUSINESSWIRE
    06 Sep 2024
    Share Share
    Xspray's XS003 Shows Matching Bioavailability At Lower Dose
    Xspray's XS003 Shows Matching Bioavailability At Lower Dose

    09 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240709122699/en

    BUSINESSWIRE
    09 Jul 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search